Document is current
Any future updates will be listed below
-
Authors
Dourron, Haley Maria https://orcid.org/0000-0002-1589-4081
Bradley, Melissa K.
Copes, Heith
Nicholas, Christopher R.
Turner, Jessica A.
Allen-Clark, Gaige
Hendricks, Peter S.
-
Funding
Funding for this research was provided by:
Source Research Foundation
Linköping University
- License Information
-
More Information
Article History
Received: 11 September 2025
Accepted: 12 February 2026
First Online: 17 March 2026
Declarations
:
: Haley Maria Dourron, Melissa Bradley, Heith Copes, Christopher R. Nicholas, Jessica Turner, and Gaige Allen-Clark declare that they have no conflict of interest. Peter S. Hendricks was previously in paid advisory relationships with Eleusis Benefit Corporation, Reset Pharmaceuticals Inc., and Silo Pharma and is currently in paid advisory relationships with Bright Minds Biosciences Ltd. and Journey Colab Corporation. He is also a co-founder of Equulus Therapeutics and Mycelial Health.
: The Institutional Review Board approved this study at the University of Alabama at Birmingham (IRB-300009865). All methods were performed in accordance with the relevant guidelines and regulations, including the Helsinki Declaration.
